Preoperative systemic chemotherapy does not benefit for appendiceal pseudomyxoma peritonei.

ANZ journal of surgery(2023)

引用 2|浏览3
暂无评分
摘要
PSC does not increase the risk of major perioperative complications in patients with appendiceal PMP, but it also does not bring postoperative survival benefits to patients either.
更多
查看译文
关键词
cytoreductive surgery,preoperative systemic chemotherapy,prognosis,pseudomyxoma peritonei,single center
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要